4:31 PM ET
10-Q
Financial Results
Hepion Pharmaceuticals Q3 2026 Results: Net Loss of $4.58M, Loss Widens
Hepion Pharmaceuticals reported a net loss of $6.6 million for the nine months ended September 30, 2026, compared to a $7.6 million loss in the prior year period. The company's financial position shows a stockholders' deficit of $4.0 million, and management highlighted significant uncertainties regarding their ability to raise additional capital to continue as a going concern.
- Key figure
- Net loss $4.58M